Eli Lilly (Suisse) SA is a Originators company based in Vernier (Geneva) recorded by Swissmedic as the authorisation holder for 39 human medicines. That places it 41 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Biotechnologika.

Key facts

SectorOriginators
CityVernier
CantonGeneva
Authorisation holderYes
Medicines39
FoundedNot available
Employees51-200
Parent groupEli Lilly and Company
ActivityNot available
Websitelilly.ch

Medicines authorised in Switzerland

Eli Lilly (Suisse) SA is recorded by Swissmedic as the authorisation holder for 39 human medicines. The table shows 39 of them with product code and dispensing category.

Portfolio by product code

  • Biotechnologika25
  • Synthetika13
  • Radiopharmazeutika1

Portfolio by dispensing category

  • B30
  • A9

39 of 39 authorisations

NameAuthorisation numberDispensing categoryATCFirst authorised
Abasaglar cartouche 100 U/ml65067B-2015-07-09
Abasaglar KwikPen 100 U/ml65069BA10AE042015-07-09
Adcirca62169BG04BE082011-11-08
Alimta 500 mg57039AL01BA042005-01-21
Amyvid 800 MBq/ml62897A-2014-01-09
Cialis 20 mg56018BG04BE082004-05-04
Cyramza 100mg/10ml65206AL01FG022015-10-29
Emgality 120 mg67026BN02CD022019-03-29
Fluctine 20 mg46347BN06AB031991-03-26
Forsteo 250 μg/mL56007BH05AA022003-08-08
Humatrope 6 mg53052AH01AC011996-07-09
Inluriyo 200 mg70233BL02BA2026-04-29
Insulin Lilly Humalog 100 U.I./ml KwikPen stylo pré-remplies59354BA10AB042009-02-02
Insulin Lilly Humalog cartouches 353553BA10AB041995-11-23
Insulin Lilly Humalog Flacon53290BA10AB041995-11-23
Insulin Lilly Humalog Mix 25 cartouches 354762BA10AB041998-09-16
Insulin Lilly Humalog Mix 25 KwikPen seringues pré-remplies59355BA10AB042009-02-02
Insulin Lilly Humalog Mix 50 cartouches 3.0 mL54763BA10AB041998-09-16
Insulin Lilly Humalog Mix 50 KwikPen seringues pré-remplies59356BA10AB042009-02-02
Insulin Lilly Huminsulin Basal cartouches 351750BA10AC011992-12-18
Insulin Lilly Huminsulin Basal KwikPen stylo prérempli61550BA10AC012011-08-16
Jaypirca 50 mg68733AL01EL2023-11-30
Kisunla 350 mg69523AN06DX052026-01-22
Lyumjev 100 units/mL67550BA10AB042020-12-03
Lyumjev 100 units/mL KwikPen67794BA10AB042020-12-03
Lyumjev cartouches 100 units/mL67793BA10AB042020-12-03
Mounjaro 2.5 mg68726BA10BX162022-11-02
Mounjaro 2.5 mg69415BA10BX2024-07-09
Mounjaro KwikPen 2.5 mg69696BA10BX162025-06-26
Olumiant 2 mg66215BL04AA372017-06-19
Omvoh 100 mg68951BL04AC242023-11-30
Omvoh 100 mg68952BL04AC242023-11-30
Omvoh 300 mg68950BL04AC242023-11-30
Retsevmo 40 mg67862AL01EX222021-02-08
Retsevmo 40 mg70214AL01EX222026-05-21
Taltz 80 mg65906BL04AC132016-12-12
Taltz 80 mg65907BL04AC132016-12-12
Trulicity 1.5 mg65236BA10BJ052015-05-06
Verzenios 50 mg66833AL01EF032019-05-21

Frequently asked questions

How many medicines does Eli Lilly (Suisse) SA have authorised in Switzerland?

Eli Lilly (Suisse) SA is recorded by Swissmedic as the authorisation holder for 39 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.

Where is Eli Lilly (Suisse) SA based?

The Swiss location recorded for Eli Lilly (Suisse) SA is Vernier, Geneva.

Is Eli Lilly (Suisse) SA a Swissmedic authorisation holder?

Yes. Eli Lilly (Suisse) SA appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.

Sources

Last updated:

Data from the Swissmedic list of authorised medicinal products as of 1 September 2026. Location, sector and website added by our own research.

About the operator

Swiss Pharma Partners

Public sources · Independent directory · Eight language versions

The Swiss Pharma Partners is an independent service and is neither affiliated with nor authorised by Swissmedic or the Federal Office of Public Health (FOPH).

Send enquiry
Ask for a Swiss partner

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swisspharmapartners.com